Older adults who have received J&J need not be concerned: expert
By
Amy Novotney
Apr 20, 2021
Joshua Sharfstein, M.D., vice dean for public health practice and community engagement at Johns Hopkins University, has a message for older adults who have received the Johnson & Johnson COVID-19 vaccine:...
J&J vaccine pause may be short, but deep concerns about staff hesitancy mounting
By
Kimberly Marselas
Apr 16, 2021
Two days after federal officials pressed pause on Johnson & Johnson’s COVID-19 vaccine, health and public policy leaders predicted it will return to use — but not without causing ongoing concern among...
LTC residents have detectable antibodies 6 months after COVID vaccination
By
Alicia Lasek
Apr 12, 2021
All residents tested in University of Pittsburgh Medical Center Senior Communities were found to have antibodies against SARS-CoV-2 after full vaccination. The findings are “cautious good news,”...
Questions to ponder as herd immunity remains out of reach
By
Steven Fuller, Ph.D., DO
Feb 08, 2021
Experts estimate that herd immunity for COVID-19 will be reached when 75–85% of the U.S. population has received the COVID-19 vaccine. But long-term care — including nursing homes and assisted...